AustralieFrV1, Main, Exploration, bibRecord, 003541

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Identifieur interne : 003541 ( Main/Exploration ); précédent : 003540; suivant : 003542

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Auteurs : A. Porwit [Canada] ; A A Van De Loosdrecht [Pays-Bas] ; P. Bettelheim [Autriche] ; L Eidenschink Brodersen [États-Unis] ; K. Burbury [Australie] ; E. Cremers [Pays-Bas] ; M G Della Porta [Italie] ; R. Ireland [Royaume-Uni] ; U. Johansson [Royaume-Uni] ; S. Matarraz [Espagne] ; K. Ogata [Japon] ; A. Orfao [Espagne] ; F. Preijers [Pays-Bas] ; K. Psarra [Grèce] ; D. Subirá [Espagne] ; P. Valent [Autriche] ; V H J. Van Der Velden [Pays-Bas] ; D. Wells [États-Unis] ; T M Westers [Pays-Bas] ; W. Kern [Allemagne] ; M C Béné [France]

Source :

Leukemia [ 1476-5551 ] ; 2014.

RBID : pubmed:24919805

Descripteurs français

KwdFr :
- Cytométrie en flux (), Europe, Humains, Organisation mondiale de la santé, Recommandations comme sujet, Syndromes myélodysplasiques (), Syndromes myélodysplasiques (diagnostic).
MESH :
- diagnostic : Syndromes myélodysplasiques.
- Cytométrie en flux, Europe, Humains, Organisation mondiale de la santé, Recommandations comme sujet, Syndromes myélodysplasiques.

English descriptors

KwdEn :
- Europe, Flow Cytometry (methods), Guidelines as Topic, Humans, Myelodysplastic Syndromes (classification), Myelodysplastic Syndromes (diagnosis), World Health Organization.
MESH :
- geographic : Europe.
- classification : Myelodysplastic Syndromes.
- diagnosis : Myelodysplastic Syndromes.
- methods : Flow Cytometry.
- Guidelines as Topic, Humans, World Health Organization.

Abstract

Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by flow cytometry (FCM) since the publication of the World Health Organization 2008 classification of myeloid neoplasms. An international working party initiated within the European LeukemiaNet and extended to include members from Australia, Canada, Japan, Taiwan and the United States has, through several workshops, developed and subsequently published consensus recommendations. The latter deal with preanalytical precautions, and propose small and large panels, which allow evaluating immunophenotypic anomalies and calculating myelodysplasia scores. The current paper provides guidelines that strongly recommend the integration of FCM data with other diagnostic tools in the diagnostic work-up of MDS.

DOI: 10.1038/leu.2014.191
PubMed: 24919805

Affiliations:

Allemagne, Australie, Autriche, Canada, Espagne, France, Grèce, Italie, Japon, Pays-Bas, Royaume-Uni, États-Unis
Angleterre, Attique (région), Bavière, District de Haute-Bavière, Grand Londres, Gueldre, Hollande-Méridionale, Hollande-Septentrionale, Ontario, Pays de la Loire, Région de Kantō, Vienne (Autriche), Washington (État)
Amsterdam, Athènes, Londres, Munich, Nantes, Nimègue, Rotterdam, Tokyo, Toronto, Vienne (Autriche)
Université de Toronto

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.</title>
<author><name sortKey="Porwit, A" sort="Porwit, A" uniqKey="Porwit A" first="A" last="Porwit">A. Porwit</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van De Loosdrecht, A A" sort="Van De Loosdrecht, A A" uniqKey="Van De Loosdrecht A" first="A A" last="Van De Loosdrecht">A A Van De Loosdrecht</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bettelheim, P" sort="Bettelheim, P" uniqKey="Bettelheim P" first="P" last="Bettelheim">P. Bettelheim</name>
<affiliation wicri:level="1"><nlm:affiliation>First Medical Department, Elisabethinen Hospital, Linz, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>First Medical Department, Elisabethinen Hospital, Linz</wicri:regionArea>
<wicri:noRegion>Linz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brodersen, L Eidenschink" sort="Brodersen, L Eidenschink" uniqKey="Brodersen L" first="L Eidenschink" last="Brodersen">L Eidenschink Brodersen</name>
<affiliation wicri:level="2"><nlm:affiliation>HematoLogics, Inc., Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HematoLogics, Inc., Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burbury, K" sort="Burbury, K" uniqKey="Burbury K" first="K" last="Burbury">K. Burbury</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cremers, E" sort="Cremers, E" uniqKey="Cremers E" first="E" last="Cremers">E. Cremers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Della Porta, M G" sort="Della Porta, M G" uniqKey="Della Porta M" first="M G" last="Della Porta">M G Della Porta</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and University of Pavia, Pavia, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and University of Pavia, Pavia</wicri:regionArea>
<wicri:noRegion>Pavia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ireland, R" sort="Ireland, R" uniqKey="Ireland R" first="R" last="Ireland">R. Ireland</name>
<affiliation wicri:level="3"><nlm:affiliation>King's College Hospital, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>King's College Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Johansson, U" sort="Johansson, U" uniqKey="Johansson U" first="U" last="Johansson">U. Johansson</name>
<affiliation wicri:level="1"><nlm:affiliation>University Hospitals, Bristol, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University Hospitals, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Matarraz, S" sort="Matarraz, S" uniqKey="Matarraz S" first="S" last="Matarraz">S. Matarraz</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca</wicri:regionArea>
<wicri:noRegion>Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogata, K" sort="Ogata, K" uniqKey="Ogata K" first="K" last="Ogata">K. Ogata</name>
<affiliation wicri:level="3"><nlm:affiliation>Metropolitan Research Center for Blood Disorders MRC JAPAN, Midorigaoka, Chofu, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Metropolitan Research Center for Blood Disorders MRC JAPAN, Midorigaoka, Chofu, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Orfao, A" sort="Orfao, A" uniqKey="Orfao A" first="A" last="Orfao">A. Orfao</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca</wicri:regionArea>
<wicri:noRegion>Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Preijers, F" sort="Preijers, F" uniqKey="Preijers F" first="F" last="Preijers">F. Preijers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, St Radboud University Medical Center, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Psarra, K" sort="Psarra, K" uniqKey="Psarra K" first="K" last="Psarra">K. Psarra</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Subira, D" sort="Subira, D" uniqKey="Subira D" first="D" last="Subirá">D. Subirá</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara</wicri:regionArea>
<wicri:noRegion>Guadalajara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Valent, P" sort="Valent, P" uniqKey="Valent P" first="P" last="Valent">P. Valent</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Der Velden, V H J" sort="Van Der Velden, V H J" uniqKey="Van Der Velden V" first="V H J" last="Van Der Velden">V H J. Van Der Velden</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wells, D" sort="Wells, D" uniqKey="Wells D" first="D" last="Wells">D. Wells</name>
<affiliation wicri:level="2"><nlm:affiliation>HematoLogics, Inc., Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HematoLogics, Inc., Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Westers, T M" sort="Westers, T M" uniqKey="Westers T" first="T M" last="Westers">T M Westers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kern, W" sort="Kern, W" uniqKey="Kern W" first="W" last="Kern">W. Kern</name>
<affiliation wicri:level="3"><nlm:affiliation>MLL Munich Leukemia Laboratory, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MLL Munich Leukemia Laboratory, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bene, M C" sort="Bene, M C" uniqKey="Bene M" first="M C" last="Béné">M C Béné</name>
<affiliation wicri:level="3"><nlm:affiliation>Service d'Hématologie Biologique, CHU de Nantes, Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Hématologie Biologique, CHU de Nantes, Nantes</wicri:regionArea>
<placeName><region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24919805</idno>
<idno type="pmid">24919805</idno>
<idno type="doi">10.1038/leu.2014.191</idno>
<idno type="wicri:Area/PubMed/Corpus">003514</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003514</idno>
<idno type="wicri:Area/PubMed/Curation">003401</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003401</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003401</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003401</idno>
<idno type="wicri:Area/Ncbi/Merge">001B12</idno>
<idno type="wicri:Area/Ncbi/Curation">001B12</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001B12</idno>
<idno type="wicri:Area/Main/Merge">003557</idno>
<idno type="wicri:Area/Main/Curation">003541</idno>
<idno type="wicri:Area/Main/Exploration">003541</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.</title>
<author><name sortKey="Porwit, A" sort="Porwit, A" uniqKey="Porwit A" first="A" last="Porwit">A. Porwit</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van De Loosdrecht, A A" sort="Van De Loosdrecht, A A" uniqKey="Van De Loosdrecht A" first="A A" last="Van De Loosdrecht">A A Van De Loosdrecht</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bettelheim, P" sort="Bettelheim, P" uniqKey="Bettelheim P" first="P" last="Bettelheim">P. Bettelheim</name>
<affiliation wicri:level="1"><nlm:affiliation>First Medical Department, Elisabethinen Hospital, Linz, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>First Medical Department, Elisabethinen Hospital, Linz</wicri:regionArea>
<wicri:noRegion>Linz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brodersen, L Eidenschink" sort="Brodersen, L Eidenschink" uniqKey="Brodersen L" first="L Eidenschink" last="Brodersen">L Eidenschink Brodersen</name>
<affiliation wicri:level="2"><nlm:affiliation>HematoLogics, Inc., Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HematoLogics, Inc., Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burbury, K" sort="Burbury, K" uniqKey="Burbury K" first="K" last="Burbury">K. Burbury</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cremers, E" sort="Cremers, E" uniqKey="Cremers E" first="E" last="Cremers">E. Cremers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Della Porta, M G" sort="Della Porta, M G" uniqKey="Della Porta M" first="M G" last="Della Porta">M G Della Porta</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and University of Pavia, Pavia, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and University of Pavia, Pavia</wicri:regionArea>
<wicri:noRegion>Pavia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ireland, R" sort="Ireland, R" uniqKey="Ireland R" first="R" last="Ireland">R. Ireland</name>
<affiliation wicri:level="3"><nlm:affiliation>King's College Hospital, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>King's College Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Johansson, U" sort="Johansson, U" uniqKey="Johansson U" first="U" last="Johansson">U. Johansson</name>
<affiliation wicri:level="1"><nlm:affiliation>University Hospitals, Bristol, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University Hospitals, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Matarraz, S" sort="Matarraz, S" uniqKey="Matarraz S" first="S" last="Matarraz">S. Matarraz</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca</wicri:regionArea>
<wicri:noRegion>Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogata, K" sort="Ogata, K" uniqKey="Ogata K" first="K" last="Ogata">K. Ogata</name>
<affiliation wicri:level="3"><nlm:affiliation>Metropolitan Research Center for Blood Disorders MRC JAPAN, Midorigaoka, Chofu, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Metropolitan Research Center for Blood Disorders MRC JAPAN, Midorigaoka, Chofu, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Orfao, A" sort="Orfao, A" uniqKey="Orfao A" first="A" last="Orfao">A. Orfao</name>
<affiliation wicri:level="1"><nlm:affiliation>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca</wicri:regionArea>
<wicri:noRegion>Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Preijers, F" sort="Preijers, F" uniqKey="Preijers F" first="F" last="Preijers">F. Preijers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, St Radboud University Medical Center, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Psarra, K" sort="Psarra, K" uniqKey="Psarra K" first="K" last="Psarra">K. Psarra</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Subira, D" sort="Subira, D" uniqKey="Subira D" first="D" last="Subirá">D. Subirá</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara</wicri:regionArea>
<wicri:noRegion>Guadalajara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Valent, P" sort="Valent, P" uniqKey="Valent P" first="P" last="Valent">P. Valent</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Der Velden, V H J" sort="Van Der Velden, V H J" uniqKey="Van Der Velden V" first="V H J" last="Van Der Velden">V H J. Van Der Velden</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wells, D" sort="Wells, D" uniqKey="Wells D" first="D" last="Wells">D. Wells</name>
<affiliation wicri:level="2"><nlm:affiliation>HematoLogics, Inc., Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HematoLogics, Inc., Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Westers, T M" sort="Westers, T M" uniqKey="Westers T" first="T M" last="Westers">T M Westers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kern, W" sort="Kern, W" uniqKey="Kern W" first="W" last="Kern">W. Kern</name>
<affiliation wicri:level="3"><nlm:affiliation>MLL Munich Leukemia Laboratory, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MLL Munich Leukemia Laboratory, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bene, M C" sort="Bene, M C" uniqKey="Bene M" first="M C" last="Béné">M C Béné</name>
<affiliation wicri:level="3"><nlm:affiliation>Service d'Hématologie Biologique, CHU de Nantes, Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Hématologie Biologique, CHU de Nantes, Nantes</wicri:regionArea>
<placeName><region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Leukemia</title>
<idno type="eISSN">1476-5551</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Europe</term>
<term>Flow Cytometry (methods)</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Myelodysplastic Syndromes (classification)</term>
<term>Myelodysplastic Syndromes (diagnosis)</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Cytométrie en flux ()</term>
<term>Europe</term>
<term>Humains</term>
<term>Organisation mondiale de la santé</term>
<term>Recommandations comme sujet</term>
<term>Syndromes myélodysplasiques ()</term>
<term>Syndromes myélodysplasiques (diagnostic)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Myelodysplastic Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Myelodysplastic Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndromes myélodysplasiques</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Flow Cytometry</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Guidelines as Topic</term>
<term>Humans</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cytométrie en flux</term>
<term>Europe</term>
<term>Humains</term>
<term>Organisation mondiale de la santé</term>
<term>Recommandations comme sujet</term>
<term>Syndromes myélodysplasiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by flow cytometry (FCM) since the publication of the World Health Organization 2008 classification of myeloid neoplasms. An international working party initiated within the European LeukemiaNet and extended to include members from Australia, Canada, Japan, Taiwan and the United States has, through several workshops, developed and subsequently published consensus recommendations. The latter deal with preanalytical precautions, and propose small and large panels, which allow evaluating immunophenotypic anomalies and calculating myelodysplasia scores. The current paper provides guidelines that strongly recommend the integration of FCM data with other diagnostic tools in the diagnostic work-up of MDS.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Autriche</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>Grèce</li>
<li>Italie</li>
<li>Japon</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Attique (région)</li>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
<li>Grand Londres</li>
<li>Gueldre</li>
<li>Hollande-Méridionale</li>
<li>Hollande-Septentrionale</li>
<li>Ontario</li>
<li>Pays de la Loire</li>
<li>Région de Kantō</li>
<li>Vienne (Autriche)</li>
<li>Washington (État)</li>
</region>
<settlement><li>Amsterdam</li>
<li>Athènes</li>
<li>Londres</li>
<li>Munich</li>
<li>Nantes</li>
<li>Nimègue</li>
<li>Rotterdam</li>
<li>Tokyo</li>
<li>Toronto</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Porwit, A" sort="Porwit, A" uniqKey="Porwit A" first="A" last="Porwit">A. Porwit</name>
</region>
</country>
<country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Van De Loosdrecht, A A" sort="Van De Loosdrecht, A A" uniqKey="Van De Loosdrecht A" first="A A" last="Van De Loosdrecht">A A Van De Loosdrecht</name>
</region>
<name sortKey="Cremers, E" sort="Cremers, E" uniqKey="Cremers E" first="E" last="Cremers">E. Cremers</name>
<name sortKey="Preijers, F" sort="Preijers, F" uniqKey="Preijers F" first="F" last="Preijers">F. Preijers</name>
<name sortKey="Van Der Velden, V H J" sort="Van Der Velden, V H J" uniqKey="Van Der Velden V" first="V H J" last="Van Der Velden">V H J. Van Der Velden</name>
<name sortKey="Westers, T M" sort="Westers, T M" uniqKey="Westers T" first="T M" last="Westers">T M Westers</name>
</country>
<country name="Autriche"><noRegion><name sortKey="Bettelheim, P" sort="Bettelheim, P" uniqKey="Bettelheim P" first="P" last="Bettelheim">P. Bettelheim</name>
</noRegion>
<name sortKey="Valent, P" sort="Valent, P" uniqKey="Valent P" first="P" last="Valent">P. Valent</name>
</country>
<country name="États-Unis"><region name="Washington (État)"><name sortKey="Brodersen, L Eidenschink" sort="Brodersen, L Eidenschink" uniqKey="Brodersen L" first="L Eidenschink" last="Brodersen">L Eidenschink Brodersen</name>
</region>
<name sortKey="Wells, D" sort="Wells, D" uniqKey="Wells D" first="D" last="Wells">D. Wells</name>
</country>
<country name="Australie"><noRegion><name sortKey="Burbury, K" sort="Burbury, K" uniqKey="Burbury K" first="K" last="Burbury">K. Burbury</name>
</noRegion>
</country>
<country name="Italie"><noRegion><name sortKey="Della Porta, M G" sort="Della Porta, M G" uniqKey="Della Porta M" first="M G" last="Della Porta">M G Della Porta</name>
</noRegion>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Ireland, R" sort="Ireland, R" uniqKey="Ireland R" first="R" last="Ireland">R. Ireland</name>
</region>
<name sortKey="Johansson, U" sort="Johansson, U" uniqKey="Johansson U" first="U" last="Johansson">U. Johansson</name>
</country>
<country name="Espagne"><noRegion><name sortKey="Matarraz, S" sort="Matarraz, S" uniqKey="Matarraz S" first="S" last="Matarraz">S. Matarraz</name>
</noRegion>
<name sortKey="Orfao, A" sort="Orfao, A" uniqKey="Orfao A" first="A" last="Orfao">A. Orfao</name>
<name sortKey="Subira, D" sort="Subira, D" uniqKey="Subira D" first="D" last="Subirá">D. Subirá</name>
</country>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Ogata, K" sort="Ogata, K" uniqKey="Ogata K" first="K" last="Ogata">K. Ogata</name>
</region>
</country>
<country name="Grèce"><region name="Attique (région)"><name sortKey="Psarra, K" sort="Psarra, K" uniqKey="Psarra K" first="K" last="Psarra">K. Psarra</name>
</region>
</country>
<country name="Allemagne"><region name="Bavière"><name sortKey="Kern, W" sort="Kern, W" uniqKey="Kern W" first="W" last="Kern">W. Kern</name>
</region>
</country>
<country name="France"><region name="Pays de la Loire"><name sortKey="Bene, M C" sort="Bene, M C" uniqKey="Bene M" first="M C" last="Béné">M C Béné</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003541 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003541 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24919805
   |texte=   Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24919805" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.